Stories - Eye on Innovation Archives - Insights

New assay can detect fusions in 1,445 genes across wide range of tumors

Chris Bahnsen — Mon, 20 Apr 2026 13:00:00 +0000

New wtRNA-seq test detects fusions in 1,445 genes with high accuracy, improving cancer diagnosis, treatment decisions, and clinical trial eligibility.

The post New assay can detect fusions in 1,445 genes across wide range of tumors appeared first on Insights.

From Intake to Interpretation: How AI Assists Lab Teams Today

jgilligan1 — Mon, 23 Mar 2026 13:00:00 +0000

Mayo Clinic Laboratories is applying AI where it helps most today, strengthening daily workflows while keeping experts firmly in control. From faster specimen intake and triage to data‑informed scheduling, first‑pass support for complex analyses, draft interpretive reporting, and reliable digital pathology quantification, teams use AI to organize information, reduce repetitive steps, and improve consistency. Human‑in‑the‑loop oversight, fit‑for‑workflow design, and regulatory‑aware communication keep the focus on safe, practical gains that benefit patients, clinicians, and laboratorians.

The post From Intake to Interpretation: How AI Assists Lab Teams Today appeared first on Insights.

Cultivating a comprehensive test menu for organ transplant patients

Chris Bahnsen — Fri, 30 Jan 2026 14:00:00 +0000

Viral and pharmacogenomic testing help clinicians detect infection early, tailor immunosuppression, and improve long-term outcomes for organ transplant recipients.

The post Cultivating a comprehensive test menu for organ transplant patients appeared first on Insights.

Transforming laboratory medicine through AI: From promise to practice

jgilligan1 — Mon, 06 Oct 2025 13:00:00 +0000

Artificial intelligence (AI) is reshaping laboratory medicine, not as a distant promise, but as a practical tool improving diagnostics, workflows, and quality. Through collaborative development, rigorous validation, and a commitment to ethical innovation, Mayo Clinic Laboratories is implementing AI-driven solutions that enhance precision, reduce turnaround times, and empower laboratorians to focus on what matters most: patient care.

The post Transforming laboratory medicine through AI: From promise to practice appeared first on Insights.

A simpler path to answers for patients with mast cell activation syndrome

Chris Bahnsen — Mon, 11 Aug 2025 13:00:00 +0000

A random urine test panel aids in diagnosing mast cell activation syndrome (MCAS), a complex condition often misdiagnosed due to overlapping symptoms. The panel improves access, speeds up diagnosis, and enables individualized treatment by detecting key mast cell mediators.

The post A simpler path to answers for patients with mast cell activation syndrome appeared first on Insights.

Precision in the pancreas: A new genetic test transforms hereditary pancreatitis diagnosis and care

jgilligan1 — Tue, 24 Jun 2025 13:00:00 +0000

Mayo Clinic Laboratories’ newly expanded Hereditary Pancreatitis Gene Panel is transforming how clinicians diagnose and manage a complex, often elusive disease. Developed through close collaboration between lab scientists, genetic counselors, and clinicians, the test uses a whole exome sequencing backbone to analyze nine carefully selected genes with strong clinical relevance. This focused approach avoids ambiguous results while empowering early diagnosis, cancer risk assessment, and family testing. Built on a whole exome backbone with reflex capabilities, the panel represents a major step forward in precision medicine — offering clarity for patients and providers, and a platform for future genomic innovation.

The post Precision in the pancreas: A new genetic test transforms hereditary pancreatitis diagnosis and care appeared first on Insights.

Neurofilament light chain test helps in diagnosis, treatment, and prognosis of ALS and MS

Chris Bahnsen — Mon, 14 Apr 2025 13:00:00 +0000

By using a test that measures neurofilament light chain (Nfl) proteins in blood, clinicians can better diagnose devastating diseases like ALS and MS, help predict disease progression, and better assess efficacy of existing drugs and trial therapies.

The post Neurofilament light chain test helps in diagnosis, treatment, and prognosis of ALS and MS appeared first on Insights.

New test distinguishes between prion disease and other causes of rapidly progressive dementia

Chris Bahnsen — Mon, 03 Feb 2025 14:00:00 +0000

Performed on cerebrospinal fluid, Mayo Clinic’s RT-QuIC prion test can distinguish prion disease from other types of rapidly progressive dementias to enhance patient care.

The post New test distinguishes between prion disease and other causes of rapidly progressive dementia appeared first on Insights.

Driving change in women’s health testing through pioneering research and novel testing strategies

Robin Huiras-Carlson — Mon, 02 Dec 2024 14:00:00 +0000

New diagnostic tests specifically for conditions that predominantly or only affect women, such as autoimmune diseases and gynecological cancers, are empowering female patients and their physicians to make informed decisions.

The post Driving change in women’s health testing through pioneering research and novel testing strategies appeared first on Insights.

Diagnostic ecosystem boosts access to timely Alzheimer’s disease testing

Barbara J. Toman — Mon, 21 Oct 2024 13:15:00 +0000

Mayo Clinic Laboratories has developed a cutting-edge suite of Alzheimer's disease testing. The newest assays use blood samples, avoiding the need for lumbar punctures to obtain cerebrospinal fluid. The testing suite exemplifies Mayo Clinic Laboratories' innovative business approach. As a platform company, Mayo Clinic is creating a diagnostics ecosystem to meet a wide range of testing needs and help physicians order the right tests for their patients.

The post Diagnostic ecosystem boosts access to timely Alzheimer’s disease testing appeared first on Insights.